BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Cisplatin
,
rs4950928
,
IL1A
,
T cell differentiation
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dexverapamil
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CYP2A7
CSNK2A1
SCN5A
CA1
AQP8
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
heterocyclic compound binding
PUJANA_BRCA1_PCC_NETWORK
PILON_KLF1_TARGETS_DN
regulation of nitrogen compound metabolic process
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Explore Curated Studies Results
Literature
Most Relevant Literature
Verapamil ameliorates proximal tubular epithelial cells apoptosis and fibrosis in diabetic kidney.
Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review.
Contribution analysis of metabolic tissues on systemic exposure of an active metabolite after oral a…
Mathematical planning of the liquid-liquid extraction procedure: a forensic chemical study of verapa…
Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumo…
A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions
ctDNA Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ NSCLC in the MDT Diagnostic …
Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ